| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 200 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 192 |
| 2 | TACROLIMUS OINTMENT 0.1% | 192 |
| 3 | MYCOPHENOLATE MOFETIL | 149 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 149 |
| 5 | PREDNISONE | 115 |
| 6 | ACETAMINOPHEN | 93 |
| 7 | RITUXIMAB | 88 |
| 8 | CYCLOPHOSPHAMIDE | 83 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 83 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 12 | 0.0344 |
| 1 | CAROSPIR | 1 | 0.0167 |
| 2 | TREOSULFAN | 38 | 0.0138 |
| 3 | LIFILEUCEL | 3 | 0.0105 |
| 4 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 5 | ELAPEGADEMASE-LVLR | 2 | 0.0067 |
| 6 | DARIFENACIN HYDROBROMIDE | 4 | 0.0046 |
| 7 | EPHEDRINE SULFATE | 1 | 0.0046 |
| 8 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 9 | PEGFILGRASTIM-JMDB | 2 | 0.0044 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 272 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 155 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 134 |
| 3 | Alkylating Drug [EPC] | 97 |
| 4 | Interleukin-23 Antagonist [EPC] | 89 |
| 5 | Kinase Inhibitor [EPC] | 86 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 77 |
| 7 | Human Immunoglobulin G [EPC] | 75 |
| 8 | Janus Kinase Inhibitor [EPC] | 74 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 72 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 2 | Human Immunoglobulin G [EPC] | 75 | 0.0036 |
| 3 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 4 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 2 | 0.0027 |
| 5 | Cortisol Synthesis Inhibitor [EPC] | 2 | 0.0026 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 7 | Provitamin D2 Compound [EPC] | 66 | 0.0022 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 11 | 0.0019 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 6 | 0.0018 |